GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Cash per Share

Realcan Pharmaceutical Group Co (SZSE:002589) Cash per Share : ¥2.67 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Realcan Pharmaceutical Group Co's Cash per Share for the quarter that ended in Mar. 2024 was ¥2.67.


Realcan Pharmaceutical Group Co Cash per Share Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Cash per Share Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 3.85 3.04 3.55 3.36

Realcan Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.65 4.19 3.72 3.36 2.67

Realcan Pharmaceutical Group Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Realcan Pharmaceutical Group Co's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Realcan Pharmaceutical Group Co's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Realcan Pharmaceutical Group Co  (SZSE:002589) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Realcan Pharmaceutical Group Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines